课题基金 / 基金详情

LATENT MEMBRANE PROTEIN-1 OF EBV IN THE RECOGNITION OF INFECTED B LYMPHOCYTES

LATENT MEMBRANE PROTEIN-1 OF EBV IN THE RECOGNITION OF INFECTED B LYMPHOCYTES
EBV 潜膜蛋白-1 在识别感染 B 淋巴细胞中的作用
批准号:
3839151
负责人:
Zoya B Kurago
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Zoya B Kurago的其他基金

相似基金

相关文献

中文摘要
翻译
EB病毒(EBV),疱疹病毒家族的一员, 感染了大多数人,并可能无限期地留在体内, 一般是以潜伏感染的形式EB病毒可以转化B- 淋巴细胞并使其永生化。EB病毒被认为是 许多疾病的原因,包括恶性肿瘤, 免疫功能低下的患者。 T淋巴细胞在控制免疫系统中起着至关重要的作用。 转化的B细胞群。一些潜伏的病毒蛋白 在识别感染的B- 杀伤性T淋巴细胞。 该项目旨在研究T细胞溶细胞克隆, 识别潜伏膜蛋白-1(LMP-1)的部分, 由I类主要抗原呈递给T细胞受体 组织相容性复合物分子(MHC)。大约100 已经产生了针对EBV的溶细胞T细胞克隆, 感染的B细胞和部分特征。
英文摘要
Epstein-Barr virus (EBV), a member of the herpes virus family, infects most humans and may remain in the body indefinitely, generally in the form of a latent infection. EBV can transform B- lymphocytes and cause their immortalization. EBV is said to be the cause of a number of diseases including malignancies in the immunocompromised patients. T-lymphocytes are of primary importance in controlling the transformed B-cell population. Some of the latent viral proteins are known to be important in the recognition of infected B- lymphocytes by killer T-lymphocytes. This project is designed to study T-cell cytolytic clones, that recognize portions of the Latent Membrane Protein-1 (LMP-1), which are presented to the T-cell receptor by Class I major histocompatibility complex molecules (MHC). Approximately 100 cytolytic T-cell clones have already been generated against EBV- infected B-cells and partially characterized.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NATURAL KILLER CELLS MAY RECOGNIZE HLA CLASS I-PEPTIDE COMBINATIONS
  • 批准号:
    3775601
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Zoya B Kurago
  • 依托单位:
海外基金